An incrementally adjustable wound retractor, which provides access to a body cavity, includes an inner ring having a diameter greater than the desired diameter of the wound incision, an outer ring having an annular axis and a diameter greater than the desired diameter of the wound incision, and a flexible sleeve disposed in a generally cylindrical form between the inner and outer rings. The outer ring includes first and second circular tubes spaced apart axially with each including a lumen having a rigid, noncompliant split hoop placed therein. The outer ring may be rolled over itself and around the annular axis to retract the sleeve with sufficient force to stretch the incision to the desired diameter. A gel cap seal may be coupled to the outer ring outside of the biological body to seal the opening produced by the wound retractor between the body cavity and outside the body cavity.

Patent
   7815567
Priority
Oct 14 2005
Filed
Oct 12 2006
Issued
Oct 19 2010
Expiry
Nov 04 2027
Extension
388 days
Assg.orig
Entity
Large
130
298
all paid
15. A surgical access device suitable for laparoscopic access to a body cavity through a body wall, the surgical access device comprising:
a proximal end, a distal end, and a longitudinal axis;
a body wall retractor comprising a deformable inner ring, an outer ring comprising an annular axis, and a tubular sleeve extending from the inner ring to the outer ring, wherein
the longitudinal axis extends through the inner ring, the outer ring, and the tubular sleeve,
the inner ring is insertable into a body cavity through an opening in a body wall, and
the outer ring has a neutral state in which the outer ring is substantially non-compliant, and a transitional state in which the outer ring is rotated around the annular axis, thereby adjusting a length of the tubular sleeve wrapped around the outer ring, and
a cap engagable with the outer ring.
1. A surgical access device, comprising:
a wound retractor for retracting an opening in a biological body wall, the wound retractor having,
an outer ring having an annular axis and adapted for juxtaposition with an outer surface of the biological body wall,
an inner ring adapted for juxtaposition with an inner surface of the biological body wall, and
a sleeve coupling the outer ring to the inner ring, the sleeve being adapted to traverse the opening in the body wall,
wherein the outer ring has a neutral state and a transitional state,
in the neutral state, the outer ring is substantially noncompliant, and
in the transitional state, the outer ring rolls over itself around the annular axis to roll the sleeve around the outer ring to retract and seal the opening in the body wall; and
a gel cap adapted for being coupled to the substantially noncompliant outer ring of the wound retractor, the gel cap having,
a cap ring adapted to be coupled to the outer ring of the wound retractor, the cap ring comprising a proximal portion, a distal portion, and a plurality of apertures extending through a wall at the proximal portion of the cap ring, and,
a gel pad, wherein portions of the gel pad extend through the plurality of apertures, thereby mechanically coupling the gel pad to the cap ring through the plurality of apertures, the gel pad being made of a gel material, the gel pad including an access portion for providing a passage from external the body to a body cavity, the passage forming an instrument seal in the presence of an instrument inserted therethrough and a zero seal in the absence of an instrument inserted therethrough.
2. The surgical access device of claim 1, the outer ring of the wound retractor having a lumen, and further comprising:
a substantially noncompliant hoop positioned in the lumen of the outer ring of the wound retractor.
3. The surgical access device of claim 2, the outer ring of the wound retractor having two lumens, and further comprising:
a substantially noncompliant hoop positioned in each of the two lumens of the outer ring of the wound retractor.
4. The surgical access device of claim 1, the sleeve including a material that is flexible and impermeable to fluids and bacteria.
5. The surgical access device of claim 1, the inner ring being made of materials having sufficient hardness to retain the shape of the inner ring after insertion of the inner ring into a body cavity.
6. The surgical access device of claim 1, the outer ring being made of materials that allow the outer ring to be turned around its annular axis.
7. The surgical access device of claim 1, the cap ring of the gel cap comprising:
a cylindrical ring having a plurality of lips at the distal end of the cap ring, each of the lips curving radially inward from the wall of the cap ring and extending around a portion of the circumference of the cap ring,
wherein the lips are configured to receive the outer ring of the wound retractor such that the outer ring is positioned between the lips and the gel pad.
8. The surgical access device of claim 1, wherein the distal portion of the cap ring is adapted to receive the outer ring of the wound retractor such that the outer ring of the wound retractor embeds into the gel pad and displaces the gel, thereby forming a seal between the gel pad and the outer ring and sleeve of the wound retractor.
9. The surgical access device of claim 1, the access portion of the gel pad including a plurality of intersecting dead-end slits.
10. The surgical access device of claim 7, the distal end of the cap ring including three lips, the three lips being equally spaced about the circumference of the cap ring.
11. The surgical access device of claim 7, the distal end of the cap ring including more than three lips, the more than three lips being equally spaced about the circumference of the cap ring.
12. The surgical access device of claim 7, the distal end of the cap ring including two lips, the two lips being diametrically opposed about the circumference of the cap ring and each of the two lips extending a sufficient distance around the circumference of the cap ring to facilitate adequate coupling of the gel cap to the outer ring of the wound retractor.
13. The surgical access device of claim 1 wherein the gel pad covers and seals the entire opening in the cap ring.
14. The surgical access device of claim 1, wherein the gel pad is adapted to cover the entire wound opening.
16. The surgical access device of claim 15, wherein the outer ring comprises at least one lumen.
17. The surgical access device of claim 16, further comprising a substantially noncompliant hoop disposed in the at least one lumen.
18. The surgical access device of claim 15, wherein the outer ring comprises an elliptical cross-section.
19. The surgical access device of claim 15, wherein the cap is releasably engagable with the outer ring.
20. The surgical access device of claim 15, wherein the cap comprises an instrument access portion.
21. The surgical access device of claim 15, wherein the cap comprises an annular cap ring and a gel pad, wherein at least a portion of the gel pad is disposed within the annular cap ring; and the cap ring is engagable with the outer ring.
22. The surgical access device of claim 21, wherein the gel pad comprises an elastomeric gel.

This invention relates substantially to devices and other apparatuses facilitating sealed access with surgical instruments, such as a surgeon's hand, across a body wall and into a body cavity.

In several areas of surgery there exists a need to have mechanisms or devices that can seal a body cavity or space, and yet permit the introduction of surgical instruments such as guidewires, endoscopes, and even the hand of a surgeon. Typical of these areas of surgery is laparoscopic surgery that relies on surgical instruments inserted through the abdominal wall to reach an operative site within the abdominal cavity. In order to increase space around the operative site within the cavity, insufflation gases are typically introduced to inflate the cavity and elevate the abdominal wall. The pressurizing of the abdominal cavity is referred to as pneumoperitoneum. In this context, the need to seal the body cavity or space arises from the need to maintain the pneumoperitoneum even when instruments are present.

Trocars have been commonly used to provide instrument access in laparoscopic surgeries. These trocars have included elaborate seal structures having zero seals that prevent the escape of the gases in the absence of instruments, and instrument seals that prevent the escape of the gases in the presence of instruments. Unfortunately, the instrument seals have been able to accommodate only a narrow range of instrument diameters. Multiple seal pairs had to be provided where wider ranges were desired.

Some instruments, such as the hand of the surgeon, have been too large for trocar access. Under these circumstances, hand-assisted laparoscopic seals have been provided. Such devices have been large, cumbersome, and largely ineffective in providing the required sealing mechanism. Other access devices, such as Touhy-Borst seals, have been used, but only for very small diameter access such as that required by a guidewire.

Each of the prior devices suffers from drawbacks that make the device difficult or cumbersome to use. For example, a Touhy-Borst seal requires two hands to use and does not form a seal when a guidewire or other device is about to be introduced. Present trocar seals and hand-assisted seals require two valves, one forming an instrument seal in the presence of the instrument, and the other forming a zero seal in the absence of the instrument. For example, in hand-assisted devices, elaborate mechanisms have been required to seal around the surgeon's arm. When the arm is removed, a separate zero seal has been required to prevent the escape of blood or insufflation gases.

The invention is directed to a gel cap that is adapted for being coupled to a wound retractor. The wound retractor has a substantially noncompliant outer ring that is adapted for juxtaposition with an outer surface of a biological body wall and for disposition relative to an incision in the body wall. The wound retractor also includes an inner ring that is adapted for juxtaposition with an inner surface of the biological body wall and for disposition relative to the incision in the body wall. The wound retractor further includes a sleeve that is adapted to traverse the incision in the body wall. The sleeve of the wound retractor couples the outer ring to the inner ring. The wound retractor is adapted to retract and seal the incision. The gelcap includes a cap ring and a gel pad. The cap ring includes a substantially cylindrical ring that has a first, proximal portion, a second, distal portion, and a plurality of lips at a distal end of the distal portion. Each of the lips curves radially inward from the wall of the distal portion of the cap ring and extends around a portion of the circumference of the cap ring. The gel pad, which is made of a gel material, is coupled to the cap ring and positioned at the proximal portion of the cap ring. The gel pad includes an access portion for providing a passage from external the biological body to a biological body cavity. The passage forms an instrument seal in the presence of an instrument inserted therethrough and a zero seal in the absence of an instrument inserted therethrough. The lips are configured to receive the outer ring of the wound retractor such that the outer ring is positioned between the lip and the gel pad. The gel pad is adapted to be placed in juxtaposition with the incision.

In one aspect, the proximal portion of the cap ring includes a plurality of apertures that are distributed about the circumference of the cap ring. The apertures extend through the wall of the proximal potion of the cap ring. In one aspect, the gel of the gel pad covers and fills the apertures. In another aspect, the gel in the apertures connects the gel at an outer portion of the cap ring to the gel at an inner portion of the cap ring. In another aspect, the gel of the gel cap extends into the distal portion of the cap ring. In one aspect, the distal portion of the cap ring is adapted to receive the outer ring of the wound retractor such that the outer ring of the wound retractor embeds into the gel pad at the distal portion of the cap ring and displaces the gel. Having the outer ring of the wound retractor embed into the gel pad forms a seal between the gel pad and the outer ring and sleeve of the wound retractor. In another aspect, the access portion of the gel pad includes a plurality of intersecting dead-end slits. In another aspect, the distal portion of the cap ring includes three lips that are substantially equally spaced about the circumference of the distal portion of the cap ring. In another aspect, each of the three lips extends about 60° around the circumference of the cap ring. In another aspect, the distal portion of the cap ring includes more than three lips. The more than three lips are substantially equally spaced about the circumference of the distal portion of the cap ring In another aspect, the distal portion of the cap ring includes two lips. The two lips are substantially diametrically opposed about the circumference of the distal portion of the cap ring. Each of the two lips extends a sufficient distance around the circumference of the cap ring to facilitate adequate coupling of the gel cap to the outer ring of the wound retractor. In another aspect, the cap ring is made of a polymer. In one aspect, the polymer is polyethylene while in another aspect the polymer is polycarbonate In another aspect, the gel pad covers and seals the entire opening in the cap ring. In another aspect, the gel pad is adapted to cover substantially the entire wound opening.

These and other features and advantages of the invention will become more apparent with a discussion of embodiments in reference to the associated drawings.

FIG. 1 is a top perspective view of a gel cap of the invention placed onto a wound retractor of the invention;

FIG. 2aillustrates an elevation view of an incrementally adjustable wound retractor in accordance with an embodiment of the invention;

FIG. 2billustrates a perspective view of the wound retractor of FIG. 2a;

FIGS. 3a-3cillustrate the retraction of the outer ring of the wound retractor of FIG. 1 to retract an incision;

FIG. 4 depicts a plan view, in cross section, of the outer ring of the wound retractor having a split hoop in a lumen thereof;

FIG. 5 depicts an elevation view of the outer ring of the wound retractor having a split hoop in the lumen of each of the first and second circular tubes of the outer ring;

FIG. 6 depicts a perspective view of the wound retractor;

FIGS. 7a-7billustrate different processes of forming the outer ring of the invention;

FIG. 8 illustrates the wound retractor of FIG. 1 deployed in an incision;

FIG. 9 depicts a perspective view of the wound retractor having the split hoops in the lumen of each of the first and second circular tubes of the outer ring;

FIG. 10 depicts a plan view of one of the first and second circular tubes of the outer ring with a split hoop placed therein with the split hoop and circular tube in their neutral state;

FIG. 11 depicts a plan view of one of the first and second circular tubes of the outer ring with a split hoop placed therein with the split hoop and circular tube in their expanded state;

FIG. 12 depicts a plan view of the first circular tube and split hoop and the second circular tube and split hoop with the first circular tube and split hoop in their neutral state and the second circular tube and split hoop in their expanded state being rolled around the first circular tube and split hoop

FIG. 13 is a side view of a wound retractor of the invention being inserted into a wound in a body wall with the inner ring being inserted into the wound;

FIG. 14 is a side view of the wound retractor of the invention placed in the wound in the body wall and depicting a direction for rolling the outer ring to retract the wound;

FIG. 15 is a side view of the wound retractor invention placed in the wound in the body wall with the wound retracted;

FIG. 16 is a top plan view of a cap ring portion of a gel cap of the invention configured for coupling the gel cap to the outer ring of the wound retractor;

FIG. 17 is a bottom perspective view of the cap ring of FIG. 16 depicting lips for engaging the outer ring of the wound retractor;

FIG. 18 is a top perspective view of the cap ring of FIG. 16;

FIG. 19 is a side cross-sectional view of the cap ring of FIG. 16;

FIG. 20 is a side cross-sectional view of the gel cap incorporating the cap ring of FIG. 16;

FIG. 21 is a bottom perspective view of the gel cap of FIG. 20;

FIG. 22 is a top perspective view of the gel cap of FIG. 20;

FIG. 23 is a top perspective view of the gel cap of FIG. 20 coupled to the outer ring of the wound retractor;

FIG. 24 is a partial section view of the gel cap of FIG. 20 coupled to the outer ring of the wound retractor; and

FIG. 25 is a side view of the gel cap of FIG. 20 coupled to the outer ring of the wound retractor.

FIGS. 1, 2a and 2b illustrate a wound retractor 100 and gel cap 200 in accordance with an embodiment of the invention. The wound retractor 100 includes a double-tube outer ring 102, an inner ring 104, and a distensible sleeve 106 coupling the outer ring 102 to the inner ring 104. The sleeve 106 may be coupled to the outer ring 102 and the inner ring 104 by heat seal, adhesive, or other means that are well known in the art. The sleeve 106 may be made of a material that is flexible and impermeable to fluids and bacteria. The inner ring 104 may be made of materials having sufficient hardness to retain its shape after insertion of the inner ring into a body cavity 404 (FIG. 8). The materials of which the outer ring 102 is made must allow the outer ring 102 to be turned around its annular axis as further described below and illustrated in FIGS. 3a-3c. The shape of the outer ring 102 affects both its ability to grip and to provide stability during and after adjustment The double-tube outer ring 102 includes a first circular tube 108 and a second circular tube 110 that are separated axially and may be coupled together by a small web 112. Each of the circular tubes 108 and 110 includes a lumen.

Referring to FIGS. 4-6, a wound retractor 100 may include the double-tube outer ring 102 having a substantially noncompliant, split hoop 118 positioned in the lumen of the first circular tube 108 and a substantially noncompliant, split hoop 118 positioned in the lumen of the second circular tube 110. Each of the split hoops 118 includes a hoop having a single split 120 about its circumference with the split creating a first end 122 of the split hoop and a second end 124 of the split hoop. In its neutral position, the first and second ends 122, 124 of the respective split hoops 118 substantially abut each other.

The substantially noncompliant hoops 118 may be made of metals, such as stainless steel, piano wire heat treated to a spring temper, or other metals that produce a substantially noncompliant hoop. The substantially noncompliant hoops 118 may also be formed of rigid polymeric materials through molding, machining, and other processes that are well known in the art. The substantially noncompliant hoops 118 may also be formed of other suitable rigid materials that are well known in the art.

As shown in FIGS. 7a-7b, the outer ring 102 may be formed by transforming an extruded elastomeric double-tube into a circular ring by placing the split hoops 118 (FIGS. 4-6) into the first and second circular tubes 108, 110. This is accomplished by inserting one of the first and second ends 122, 124 of one of the hoops 118 into the lumen of the first circular tube 108 and one of the first and second ends of the other hoop 118 into the lumen of the second circular tube 110. The split hoops 118 are continually fed into the lumens until substantially each of the entire hoops 118 is within the respective circular tubes 108, 110. The extruded elastomeric tube 102 takes on the circular shape of the split hoops 118 placed in the lumens of the first and second circular tubes 108, 110.

It is appreciated that the outer ring 102 can be designed in various configurations and sizes to achieve various retraction rates and/or to conform to different body surfaces. The lumens of the first and second circular tubes 108, 110 may have cross-sections of different geometries, such as circular, oval, triangular, rectangular, any geometric shape with multiple sides, etc. The split hoops 118 may also have cross-sections of different geometries, such as circular, rectangular, oval, triangular, any geometric shape with multiple sides, etc. Advantages of the above embodiments of the invention include improved retraction adjustability and stability.

With continued reference to FIGS. 4-6 and with reference to FIGS. 7a, 7b and 8-12, with each of the first and second circular tubes 108, 110 including a split hoop 118, it is not necessary to provide means for a first end portion 126 and a second end portion 128 of the split hoop to overlap each other when rolling the sleeve 106 around the outer ring 102. Since the split hoop 118 in the each of the first and second circular tubes 108, 110 has substantially abutting first and second ends 122, 124 and no means are provided for the first and second end portions 126, 128 of the split hoops to overlap each other, each of the split hoops 118 functions as an axle about which the outer ring 102 may turn for half a rotation, or 180°. More particularly, the first circular tube 108 may be rolled outside the second circular tube 110 with the circumference of the split hoop 118 in the first circular tube expanding to clear the split hoop 118 in the second circular tube. Then the second circular tube 110 may be rolled outside the first circular tube 108 with the circumference of the split hoop 118 in the second circular tube expanding to clear the split hoop 118 in the first circular tube (see FIG. 12) These steps may be repeated until the wound 400 is retracted to the desired degree.

FIGS. 3a-3cand FIG. 8 illustrate the retraction and adjustment of the outer ring 102 to fit an incision. In accordance with the invention, the wound retractor 100 is axially adjustable in increments. In particular, the upper end of the sleeve 106 can be wrapped around the outer ring 102 so as to tightly seal the sides or edges of the incision 400. The unique shape of the outer ring 102 provides for an easy snap action when rolled about itself. The outer ring 102 also provides for incremental shortening of the sleeve 106 and for stability after installation.

FIGS. 8 and 13-15 illustrate a process of installing the wound retractor 100 in a wound opening 400. An incision 400 in the shape of a slit is first made in a body wall of a patient, such as the abdominal wall 402. The inner ring 104 is compressed and the inner ring and sleeve 106 are then manually inserted into the body cavity 404 through the incision 400 with the outer ring 102 remaining external the body cavity 404. Once the inner ring 104 is within the body cavity 404, it expands around the inner surface of the incision 400 so as to be generally parallel to the outer surface of the abdominal wall 402. The sleeve 106 provides a working channel from outside the body cavity 404 to inside the body cavity.

The outer ring 102 initially rests above the abdominal wall 402 around the wound opening 400. Since the upper end of the sleeve 106 is coupled to the outer ring 102, the sleeve 106 can be drawn upwards and radially outward or inward, thereby drawing the inner ring 104 tightly against the inner surface of the abdominal wall 402. Moreover, the intermediate portion of the sleeve 106 is drawn tightly against the sides and edges of the wound opening 400, thereby retracting the adjacent tissue and producing a tightly sealed opening to the body cavity 404. The sleeve 106 contacts the entire surface of the wound 400 and protectively covers and seals it from contamination and infection. Depending on the size and depth of the incision 400, the user can roll up the sleeve 106 by gripping the double-tube outer ring 102 and turning it in a direction 130, as also illustrated in FIGS. 3a-3c, until the sleeve 106 abuts the outer edge of the wound opening 400. The inner ring 104 is adapted for juxtaposition with the inner surface of the abdominal wall 402 and the outer ring 102 is adapted for juxtaposition with the outer surface of the abdominal wall. Both the inner ring 104 and the outer ring 102 are adapted for disposition relative to the incision 400 in the abdominal wall 402. The sleeve 106 is adapted to traverse the incision 400 in the abdominal wall 402.

An advantage of the wound retractor 100 of the present invention is it provides for an easier, faster and higher retraction rate than that known in the prior art, thereby resulting in less traumatic effects to the patient. Another advantage of the wound retractor 100 of the present invention is it provides tactile gripping and incremental rolling of the sleeve 106 about the outer ring 102. In comparison to retractors of the prior art, the substantially noncompliant hoops 118 in the lumens of the outer ring 102 provide greater strength, which in turn provides better retraction. The substantially noncompliant hoops 118 control the shape of the wound opening 400, rather than the wound opening controlling the shape of the wound retractor 100. In this manner, the wound retractor 100 of the present invention provides better isolation, protection, and sealing of the wound 400.

After surgery, the wound retractor 100 may be retrieved by grabbing the inner ring 104 and the sleeve 106 and pulling them through the wound opening 400. The use of the sleeve 106 and the ease of retracting the outer ring 102 provide higher compression between the inner and outer rings. As a result, the wound retractor 100 of the invention provides incremental adjustability to fit a wide range of incision sizes and isolates and protects the wound from bacterial infection as diseased body parts and contaminated instruments are passed through the wound.

Referring to FIGS. 16-25, the gel cap 200 includes a cap ring 202 that couples to the outer ring 102 of the wound retractor 100 and a gel pad 204 coupled to the cap ring The gel pad 204 is made of a gel material and includes an access portion 206 or passage through the gel for providing a passage from external the body to the body cavity 404. In one aspect, the access portion 206 may include a plurality of intersecting dead-end slits 228, 230. The access portion 206 forms an instrument seal in the presence of an instrument, such as the arm of a surgeon, inserted therethrough and a zero seal in the absence of an instrument inserted therethrough.

To combine the gel pad 204 with the cap ring 202, the cap ring may be placed into a mold that includes the shape of the desired gel pad and the uncured gel is added to the mold. In one aspect, the cap ring 202 includes a substantially cylindrical ring 208 having a first, proximal portion 210, a second, distal portion 212 and a longitudinal axis 214 extending through the proximal and distal portions. The gel pad 204 is positioned at the proximal portion 210 of the cap ring 202. The proximal portion 210 of the cap ring 202 may include a plurality of apertures 216 distributed about the circumference of the cap ring. The apertures 216 may extend through the wall of the proximal portion 210 of the cap ring 202. Sufficient gel may be added to the mold to cover and fill the apertures 216. When adding uncured gel into the mold, the gel flows through the apertures 216 and remains in the apertures. Also, for reasons that will be described below, sufficient gel may be added to the mold to extend into the distal portion 212 of the cap ring 202. When the gel pad 204 is cured, the gel in the apertures 216 connects the gel at the outer portion 218 of the cap ring 202 to the gel at the inner portion 220 of the cap ring, thus forming a mechanical lock between the gel and the cap ring. Alternatively, as will be described below, a separately formed gel slug 204 may be coupled to the inner surface of the proximal portion 210 of the cap ring 202.

The distal portion 212 of the cap ring 202 is substantially cylindrical and is configured to receive the outer ring 102 of the wound retractor 100. In one aspect, the distal portion 212 of the cap ring 202 includes a plurality of lips 222 at the distal end 224 thereof. The lips 222 curve radially inwardly from the wall 226 of the distal portion 212 of the cap ring 202 and extend around a portion of the circumference of the cap ring. In one aspect, there are three lips 222 that are substantially equally spaced about the circumference of the distal portion 212 of the cap ring 202. Each of the three lips 222 may extend about 60° around of the circumference of the cap ring 202, however, the lips may extend longer or shorter distances around the circumference of the cap ring. Also, there may be more than three lips 222 with each lip extending a shorter distance around the circumference of the cap ring 202 and the more than three lips being substantially equally spaced about the circumference of the distal portion of the cap ring. In another aspect, there may be two lips 222 that are substantially diametrically opposed about the circumference of the distal portion of the cap ring with each of the lips extending a sufficient distance around the circumference of the cap ring 202 to facilitate adequate coupling of the gel cap 200 to the outer ring 102 of the wound retractor 100. The lips 222 are configured to receive the distal-most circular tube 108, 110 of the outer ring 102 of the wound retractor 100 such that the outer ring is positioned between the lips 222 and the gel pad 204. More particularly, when the outer ring 102 of the wound retractor 100 is received by the distal portion 212 of the cap ring 202, the outer ring of the wound retractor embeds into the gel pad 204 at the distal portion 212 of the cap ring 202 and displaces the gel, thereby forming a seal between the gel pad and the outer ring and sleeve 106 of the wound retractor. This places the gel pad 204 in juxtaposition with the incision 400.

In use, the wound retractor 100 is first used to retract the incision in the body wall of a patient, as described above. The gel cap 200 is brought to the outer ring 102 of the wound retractor 100 at an angle, with one of the lip portions 222 of the cap ring 202 toward the patient. The lip portion 222 of the cap ring that is toward the patient is slid under the distal-most circular tube 108, 110 of the outer ring 102, between the outer ring and the patient, and then the remainder of the gel cap 200 is swung onto the outer ring with the remaining lip portions snapping into place under the distal-most circular tube. In an alternative aspect, the gel cap 200 may be brought to the outer ring 102 substantially parallel to the outer ring and the lip portions 222 snapped into place under the distal-most circular tube 108, 110 of the outer ring 102 at the same time.

The gel cap 200 with the plurality of lips 222 on the cap ring 202 is best suited for use with wound retractors 100 having an outer ring 102 that is substantially rigid and noncompliant. If the outer ring 102 of the wound retractor 100 were not rigid, the outer ring would tend to pull out of the gel cap 200, thereby compromising the seal between the gel pad 204 and the wound retractor and potentially resulting in deflation of the insufflated body cavity.

The cap ring 202 in one aspect includes a polymer, e.g., polyethylene (PE). In one aspect, the polyethylene is a low density polyethylene (LDPE) or high density polyethylene (HDPE), or ultra high molecular weight polyethylene (UHMWPE). In one aspect, the cap ring 202 may be made of a polymer, such as polycarbonate and may be fabricated by methods including injection molding.

The gel pad 204 may be coupled to, attached to, formed or integrated with the cap ring 202 so that a gas-tight conduit is formed between the cap ring and the sleeve 106. The gel pad 204 covers and seals the entire opening in the cap ring 202. Additionally, the gel pad 204 is adapted to cover substantially the entire wound 400 opening. As stated above, in one aspect the gel pad includes a plurality of intersecting dead-end slits 228, 230 that form an access portion or passage through the gel pad 204. Unlike foam rubber or other similar types of elastic materials, the gel pad 204 provides a gas tight seal around a variety of shapes and sizes of hands or instruments inserted therethrough.

In one aspect, the gel material from which the gel pad 204 is made is an elastomeric gel. Some such gels have been described in U.S. patent application Ser. No. 10/381,220, filed Mar. 20, 2003, the disclosure of which is hereby incorporated by reference as if set forth in full herein. The gel can be prepared by mixing a triblock copolymer with a solvent for the midblocks. The endblocks are typically thermoplastic materials such as styrene and the midblocks are thermoset elastomers such as isoprene or butadiene, e.g., Styrene-Ethylene-Butylene-Styrene (SEBS). In one aspect, the solvent used is mineral oil. Upon heating this mixture or slurry, the midblocks are dissolved into the mineral oil and a network of the insoluble endblocks forms. The resulting network has enhanced elastomeric properties over the parent copolymer. In one aspect, the triblock copolymer used is KRATON G1651, which has a styrene to rubber ratio of 33/67. Once formed, the gel is substantially permanent and, by the nature of the endblocks, processable as thermoplastic elastomers henceforward. The mixture or slurry has a minimum temperature at which it becomes a gel, i.e., the minimum gelling temperature (MGT). This temperature, in one aspect, corresponds to the glass transition temperature of the thermoplastic endblock plus a few degrees. For example, the MGT for the mixture of KRATON G1651 and mineral oil is about 120° C. When the slurry reaches the MGT and the transformation to a gel state takes place, the gel becomes more transparent, thereby providing means for visually confirming when the transformation of the slurry to the gel state is substantially complete and that the gel may be cooled. In addition to triblocks, there are also diblock versions of the materials that may be used where Styrene is present at only one end of the formula, for example, Styrene-Ethylene/Butylene (SEB).

For a given mass of slurry to form into a complete gel, the entire mass of the slurry is heated to the MGT and remains heated at the MGT for sufficient time for the end blocks to form a matrix of interconnections. The slurry will continue to form into gel at temperatures above the MGT until the slurry/gel reaches temperatures at which the components within the slurry/gel begin to decompose or oxidize. For example, when the slurry/gel is heated at temperatures above 250° C., the mineral oil in the slurry/gel will begin to be volatile and oxidize. Oxidizing may cause the gel to turn brown and become oily.

The speed at which a given volume of slurry forms a gel is dependant on the speed with which the entire mass of slurry reaches the MGT. Also, with the application is of temperatures higher than the MGT, this speed is further enhanced as the end block networks distribute and form more rapidly.

The various base formulas may also be alloyed with one another to achieve a variety of intermediate properties For example, KRATON G1701X is a seventy percent (70%) SEB thirty percent (30%) SEBS mixture with an overall Styrene to rubber ratio of 28/72. It can be appreciated that an almost infinite number of combinations, alloys, and Styrene to rubber ratios can be formulated, each capable of providing advantages to a particular embodiment of the invention. These advantages will typically include low durometer, high elongation, and good tear strength.

It is contemplated that the gel material may also include silicone, soft urethanes and even harder plastics that might provide the desired sealing qualities with the addition of a foaming agent. The silicone material may be of the types currently used for electronic encapsulation. The harder plastics may include PVC, Isoprene, KRATON neat, and other KRATON/oil mixtures. In the KRATON/oil mixture, oils such as vegetable oils, petroleum oils and silicone oils may be substituted for the mineral oil.

Any of the gel materials contemplated could be modified to achieve different properties such as enhanced lubricity, appearance, and wound protection. Additives may be incorporated directly into the gel or applied as a surface treatment. Other compounds may be added to the gel to modify its physical properties or to assist in subsequent modification of the surface by providing bonding sites or a surface charge. Additionally, oil based colorants may be added to the slurry to create gels of different colors.

In one aspect, the mixture/slurry used with the various embodiments of the cap rings that are described herein are composed of about ninety percent (90%) by weight of mineral oil and about ten percent (10%) by weight of KRATON G1651. From a thermodynamic standpoint, this mixture behaves similar to mineral oil. Mineral oil has a considerable heat capacity and, therefore, at about 130° C. it can take three (3) or four (4) hours to heat a pound of the slurry sufficiently to form a homogeneous gel. Once formed, the gel can be cooled as quickly as practical with no apparent deleterious effects on the gel. This cooling, in one aspect, is accomplished with cold-water immersion. In another aspect, the gel may be air-cooled. Those familiar with the art will recognize that other cooling techniques that are well known in the art may be employed and are contemplated as within the scope of the present invention.

Many of the properties of the KRATON/oil mixture will vary with adjustments in the weight ratio of the components. In general, the greater the percentage of mineral oil the less firm the mixture; the greater the percentage of KRATON, the more firm the mixture. If the resultant gel is too soft it can lead to excessive tenting or doming of the gel cap during surgery when a patients abdominal cavity is insufflated Excessive tenting or doming may cause the slits 228, 230 to open, providing a leak path. Additionally, if the gel is too soft it might not provide an adequate seal. However, the gel should be sufficiently soft to be comfortable for the surgeon while simultaneously providing good sealing both in the presence of an instrument and in the absence of an instrument.

If the slurry is permitted to sit for a prolonged period of time, the copolymer, such as KRATON, and the solvent, such as mineral oil, may separate. The slurry may be mixed, such as with high shear blades, to make the slurry more homogeneous. However, mixing the slurry may introduce or add air to the slurry. To remove air from the slurry, the slurry may be degassed. In one aspect, the slurry may be degassed in a vacuum, such as within a vacuum chamber. In one aspect, the applied vacuum may be 0.79 meters (29.9 inches) of mercury, or about one (1.0) atmosphere. The slurry may be stirred while the slurry is under vacuum to facilitate removal of the air. During degassing within a vacuum, the slurry typically expands, then bubbles, and then reduces in volume. The vacuum may be discontinued when the bubbling substantially ceases. Degassing the slurry in a vacuum chamber reduces the volume of the slurry by about ten percent (10%). Degassing the slurry helps reduce the potential of the finished gel to oxidize.

Degassing the slurry tends to make the resultant gel firmer. A degassed slurry composed of about 91.6% by weight of mineral oil and about 8.4% by weight of KRATON G1651, an eleven-to-one ratio, results in a gel having about the same firmness as a gel made from a slurry that is not degassed and that is composed of about ninety percent (90%) by weight of mineral oil and about ten percent (10%) by weight of KRATON G1651, a nine-to-one ratio.

Mineral oil is of a lighter density than KRATON and the two components will separate after mixing, with the lighter mineral oil rising to the top of the container. This separation may occur when attempting to form static slurry into gel over a period of several hours. The separation can cause the resulting gel to have a higher concentration of mineral oil at the top and a lower concentration at the bottom, e.g., a non-homogeneous gel. The speed of separation is a function of the depth or head height of the slurry being heated. The mass of slurry combined with the head height, the temperature at which the gel sets and the speed with which the energy can be transferred to the gel, factor into the determination or result of homogeneous gel versus a non-homogeneous gel.

The gel pad or gel cap in various aspects of the present invention may be gamma sterilized. The relative or comparative simplicity of qualifying the sterilization process, for example of gamma versus ethylene oxide, of the gel pad and the device with the gel pad is desirable. However, under gamma sterilization large bubbles can form in the gel pad causing potential cosmetic or aesthetic issues in the sterilized devices. The bubbles are more than ninety-nine percent (99%) room air, so removal of the dissolved air in the slurry is performed prior to forming the slurry into gel. For example, the slurry may be degassed via vacuum, as described above, and turned into gel by heat. Bubbles may still form in the gel during gamma sterilization but disappear in a period of about twenty-four (24) to seventy-two (72) hours. In one aspect, the percentage of dissolved gas in the mineral oil at room temperature is about ten percent (10%). The removal of the air in the gel has an additional effect of making the gel firmer This however is counterbalanced by the softening effect on the gel caused by gamma radiation during gamma sterilization.

If the gel pad is to be gamma sterilized, the gel may include about ninety percent (90%) mineral oil by weight and about ten percent (10%) KRATON by weight. As stated above, degassing the slurry has the effect of making the gel firmer. However, the gamma radiation softens the gel to substantially the same firmness as a gel having about ninety percent (90%) mineral oil by weight and about ten percent (10%) KRATON by weight that is not degassed and gamma sterilized.

In one aspect, cyanoacrylate, e.g., SUPERGLUE or KRAZY GLUE, may be used to bond or otherwise couple or attach the gel pad 204 to the cap ring 202. The glue may attach to either the rubber or styrene component of the tri-block and the bond is frequently stronger than the gel material itself. In another aspect, a solvent may be used to dissolve the plastics in the cap ring and the polystyrene in the gel. The solution of solvent is applied to the gel pad and cap ring in either a spray or dip form. In effect, the solution melts both the plastic of the cap ring as well as the polystyrene in the gel pad to allow a chemical bond to form between the two, which remains when the solvent evaporates.

Polyethylene can be dissolved in mineral oil and then applied to the gel pad. The mineral oil will not evaporate but will over time absorb into the gel pad and impart a polyethylene layer on the gel pad that may have some beneficial properties.

In one aspect, the gel pad 204 is cast into a DYNAFLEX or KRATON polymer support structure, e.g., the cap ring 202. By using KRATON polymer or a similar material in the cap ring, ring adhesion between the gel pad 204 and the cap ring 202 can be achieved. The polystyrene in the gel is identified as achieving adhesion with polyphenylene oxide (PPO), polystyrene and other polymers.

In the casting process the gel pad 204 and the cap ring 202 are heated to a temperature above about 130° C. and held at that temperature for several hours, e.g., about three (3) to four (4) hours. The temperature used is not sufficient to deform the cap ring 202.

As stated above, in one aspect the cap ring 202 includes a polymer, e.g., polyethylene (PE). The gel includes mineral oil. PE has a higher molecular weight than mineral oil. PE is dissolved by mineral oil at high temperatures. As such, as the PE and the mineral oil in the gel pad 204 intermix as both are heated to and held at temperatures above about 130° C., a bond between the PE and gel pad is formed.

In one aspect, the cap ring 202 includes polycarbonate. The polycarbonate of the cap ring 202 does not form bonds with the gel pad 204 at 130° C. However, by raising the temperature to about 150° C. for a few minutes during casting, bonding occurs between the gel pad 204 and the cap ring 202. As such, heating the gel pad 204 and cap ring 202 to temperatures at which both the polystyrene of the gel and the polycarbonate are simultaneously beyond their melt points allow bonds to form between the gel pad and the cap ring. Alternatively, the gel pad 204 and cap ring 202 may be heated to near or at the glass transition temperature of the polycarbonate cap ring to form the bond between the gel pad and the cap ring.

In one aspect, casting the gel pad 204 into the cap ring 202 to form a gel cap 200 includes placing the cap ring into a mold cavity of a casting mold. The mold cavity may include support for the annular walls of the cap ring 202. The mold may be made of aluminum, copper, brass, or other mold material having good heat dissipation properties. However, those familiar with the art will recognize that other mold materials having lower heat dissipation properties will produce acceptable parts and these are contemplated as within the scope of the present invention as well.

The mold cavity having the cap ring 202 is filled with the slurry such that the slurry is in contact with the cap ring. To facilitate filling voids in the mold cavity with the slurry, the slurry may be preheated, for example, to about 520° C. (1250° F.). Preheating the slurry to a temperature below the MGT reduces the viscosity of the slurry and allows the slurry to flow more easily. As stated above, the slurry may have been degassed in a vacuum. The slurry may be degassed again within the mold after the mold cavity is filled to remove air that may have been introduced during the filling of the mold cavity and to facilitate flow of the slurry into voids in the mold. Heat is applied to the mold having the cap ring 202 and the slurry, such as in an oven, until the slurry attains a temperature of about 150° C. As stated above, the slurry turns into gel at about 120° C., however, at about 150° C., the gel can bond to a polycarbonate cap ring 202. Depending on the material used to fabricate the cap ring 202, bonding may take place at temperatures other than about 150° C. If the cap ring 202 is fabricated of a material having a lower melting point than 120° C., then the gel pad 204, such as a gel slug 204, may be molded separately and then bonded to the cap ring. The slits 228, 230 may be molded into the gel pad 204 through the use of an insert in the form of the slit in the mold.

Once the temperature of the gel pad 204 reaches about 150° C., the gel cap 200 may be cooled, such as by air-cooling, cold-water immersion, or other cooling means that are well known in the art. At 150° C. the gel pad is soft and if it were distorted during cooling it would set with the distortion included. To reduce the likelihood of distorting the gel pad 204, the gel cap 200 may be cooled within the mold. Cooling times may vary based on parameters including size and configuration of the mold, quantity of gel, temperature and quantity of cooling medium, cooling medium properties and the mold material. As an example, the cooling time may be about two (2) hours if cooling in air and about fifteen (15) minutes if cooling in water. Whether cooling with air or water, the final properties of the gel are substantially the same. The gel cap 200 is typically cooled to about ambient room temperature, but may be cooled to lower temperatures. If the gel cap 200 is cooled to the freezing point of the gel, about 0° C., then the gel will freeze and become hard. This may be beneficial for other means of coupling the gel pad 204 to the cap ring 202, such as with a secondary operation. The gel cap 200 may be removed from the mold at any time after the gel has set.

When removed from the mold, the gel pad 204 typically has a tacky surface. The gel cap 200 may be coated with a powder, such as cornstarch, to substantially reduce or eliminate the tackiness of the cured gel pad 204.

As stated above, in another aspect, the gel pad 204 may be molded separately from the cap ring 202 and coupled to the cap ring by a secondary operation, such as by bonding. In one aspect, the gel pad 204 may be molded into a gel slug 204 having an outer perimeter smaller than the inner cylindrical wall of the cap ring 202 and to a height higher that the height of the cap ring. Since the gel pad 204 is being molded separate from the cap ring 202, the slurry only needs to be heated until it reaches about 120° C. and completes the transformation from slurry into gel and the gel becomes substantially transparent. The gel slug 204 may then be placed within the inner cylindrical wall of the cap ring 202. The gel slug 204 may be cooled and/or frozen prior to placing it within the inner cylindrical wall of the cap ring 202. The gel slug 204 may be coupled to the cap ring 202 through compression molding with the gel slug being compressed longitudinally so that the outer perimeter of the gel slug expands and compresses against the inner cylindrical wall of the cap ring. The gel slug 204 and cap ring 202 are heated to a sufficient temperature for the polystyrene of the gel and the polymer of the cap ring to form bonds between the gel and the cap ring. Molding the gel slug 204 separately from the cap ring 202 and heat bonding the gel slug to the cap ring at a later time is especially useful when the cap ring is made of a material that has a lower melting temperature than the MGT. In such situations, the gel slug 204 can be molded first and heat bonded to the cap ring 202 without melting the cap ring.

An advantage associated with the modified surgical access device is it enables a surgeon to quickly retract and protectively line an abdominal wall incision while being able to easily accommodate variations in abdominal wall thickness between patients. In addition, the device effectively seals around the interior and exterior of the incision, and allows a sealing cap to be coupled to the device to seal the abdominal cavity and to enable a laparoscopic procedure to be performed.

Many alterations and modifications may be made by those having ordinary skill in the art without departing from the spirit and scope of the invention. For these reasons, the above description should not be construed as limiting the invention, but should be interpreted as merely exemplary of the embodiments.

Brustad, John R., Johnson, Gary M, Albrecht, Jeremy J, Hart, Charles C

Patent Priority Assignee Title
10064649, Jul 07 2014 FREUDENBERG MEDICAL MIS, INC Pleated seal for surgical hand or instrument access
10085734, Jan 10 2012 The Board of Trustees of the Leland Stanford Junior University Systems for the prevention of surgical site infections
10172641, Aug 15 2014 Applied Medical Resources Corporation Natural orifice surgery system
10271875, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
10327751, Mar 20 2013 PRESCIENT SURGICAL, INC Methods and apparatus for reducing the risk of surgical site infections
10368908, Sep 15 2015 Applied Medical Resources Corporation Surgical robotic access system
10376282, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
10420587, Nov 12 2014 Covidien LP Attachments for use with a surgical access device
10507017, Jun 05 2002 Applied Medical Resources Corporation Wound retractor
10575840, Oct 07 2015 Applied Medical Resources Corporation Wound retractor with multi-segment outer ring
10674896, Sep 12 2016 Applied Medical Resources Corporation Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments
10675056, Sep 07 2017 Covidien LP Access apparatus with integrated fluid connector and control valve
10792071, Feb 11 2019 Covidien LP Seals for surgical access assemblies
10828065, Aug 28 2017 Covidien LP Surgical access system
10952768, Aug 15 2014 Applied Medical Resources Corporation Natural orifice surgery system
10993709, Jan 10 2012 The Board of Trustees of the Leland Stanford Junior University Systems for the prevention of surgical site infections
11000313, Apr 25 2019 Covidien LP Seals for surgical access devices
11123102, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
11160682, Jun 19 2017 Covidien LP Method and apparatus for accessing matter disposed within an internal body vessel
11166748, Feb 11 2019 Covidien LP Seal assemblies for surgical access assemblies
11191567, Nov 12 2014 Covidien LP Attachments for use with a surgical access device
11259840, Jun 21 2019 Covidien LP Valve assemblies for surgical access assemblies
11259841, Jun 21 2019 Covidien LP Seal assemblies for surgical access assemblies
11357542, Jun 21 2019 Covidien LP Valve assembly and retainer for surgical access assembly
11382658, Sep 15 2015 Applied Medical Resources Corporation Surgical robotic access system
11389193, Oct 02 2018 Covidien LP Surgical access device with fascial closure system
11399865, Aug 02 2019 Covidien LP Seal assemblies for surgical access assemblies
11413065, Jun 28 2019 Covidien LP Seal assemblies for surgical access assemblies
11413068, May 09 2019 Covidien LP Seal assemblies for surgical access assemblies
11432843, Sep 09 2019 Covidien LP Centering mechanisms for a surgical access assembly
11446058, Mar 27 2020 Covidien LP Fixture device for folding a seal member
11457949, Oct 12 2018 Covidien LP Surgical access device and seal guard for use therewith
11464540, Jan 17 2020 Covidien LP Surgical access device with fixation mechanism
11471142, Mar 15 2013 Applied Medical Resources Corporation Mechanical gel surgical access device
11471191, Feb 11 2019 Covidien LLP Seals for surgical access assemblies
11523842, Sep 09 2019 Covidien LP Reusable surgical port with disposable seal assembly
11529170, Apr 29 2020 Covidien LP Expandable surgical access port
11541218, Mar 20 2020 Covidien LP Seal assembly for a surgical access assembly and method of manufacturing the same
11576701, Mar 05 2020 Covidien LP Surgical access assembly having a pump
11583316, Aug 15 2014 Applied Medical Resources Corporation Natural orifice surgery system
11596439, Nov 07 2017 PRESCIENT SURGICAL, INC Methods and apparatus for prevention of surgical site infection
11602338, Oct 07 2015 Applied Medical Resources Corporation Wound retractor with multi-segment outer ring
11622790, May 21 2020 Covidien LP Obturators for surgical access assemblies and methods of assembly thereof
11627867, Sep 12 2016 Applied Medical Resources Corporation Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments
11642153, Mar 19 2020 Covidien LP Instrument seal for surgical access assembly
11666359, Sep 07 2017 Covidien LP Access apparatus with integrated fluid connector and control valve
11717321, Apr 24 2020 Covidien LP Access assembly with retention mechanism
11717323, Apr 25 2019 Covidien LP Seals for surgical access devices
11751908, Jun 19 2020 Covidien LP Seal assembly for surgical access assemblies
11751910, Feb 11 2019 Covidien LP Seal assemblies for surgical access assemblies
11812991, Oct 18 2019 Covidien LP Seal assemblies for surgical access assemblies
11839405, Jan 17 2020 Covidien LP Surgical access device with fixation mechanism
11883068, Sep 15 2015 Applied Medical Resources Corporation Surgical robotic access system
11925387, Oct 02 2018 Covidien LP Surgical access device with fascial closure system
11992184, Sep 12 2016 Applied Medical Resources Corporation Surgical robotic access system for irregularly shaped robotic actuators and associated robotic surgical instruments
12064141, Mar 27 2020 Covidien LP Fixture device for folding a seal member
12089872, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
12127762, Jun 21 2019 Covidien, LP Valve assembly and retainer for surgical access assembly
12127763, Mar 19 2020 Covidien LP Instrument seal for surgical access assembly
8016755, Oct 19 2000 Applied Medical Resources Corporation Surgical access apparatus and method
8070676, Oct 19 2000 Applied Medical Resources Corporation Surgical access apparatus and method
8105234, Oct 19 2000 Applied Medical Resources Corporation Surgical access apparatus and method
8109873, May 11 2007 Applied Medical Resources Corporation Surgical retractor with gel pad
8157835, Aug 14 2001 Applied Medical Resouces Corporation Access sealing apparatus and method
8187177, Sep 17 2003 Applied Medical Resources Corporation Surgical instrument access device
8226552, May 11 2007 Applied Medical Resources Corporation Surgical retractor
8235054, Jun 05 2002 Applied Medical Resources Corporation Wound retractor
8257252, Aug 06 2009 Covidien LP Elongated seal anchor for use in surgical procedures
8262568, Oct 13 2008 Applied Medical Resources Corporation Single port access system
8267858, Oct 14 2005 Applied Medical Resources Corporation Wound retractor with gel cap
8308639, Oct 14 2005 Applied Medical Resources Corporation Split hoop wound retractor with gel pad
8308755, Sep 24 2007 Cilag GmbH International Elliptical retractor
8313431, Oct 14 2005 Applied Medical Resources Corporation Split hoop wound retractor
8317690, Mar 31 2009 Covidien LP Foam port and introducer assembly
8323184, Mar 31 2009 Covidien LP Surgical access port and associated introducer mechanism
8343047, Jan 22 2008 Applied Medical Resources Corporation Surgical instrument access device
8357086, Sep 17 2003 Applied Medical Resources Corporation Surgical instrument access device
8388526, Oct 20 2001 Applied Medical Resources Corporation Wound retraction apparatus and method
8414487, Oct 14 2005 Applied Medical Resources Corporation Circular surgical retractor
8480575, Oct 13 2008 Applied Medical Resources Corporation Single port access system
8496581, Oct 19 2000 Applied Medical Resources Corporation Surgical access apparatus and method
8550992, Dec 20 2010 Covidien LP Two-part access assembly
8647265, Oct 14 2005 Applied Medical Resources Corporation Hand access laparoscopic device
8672839, Oct 19 2000 Applied Medical Resource Corporation Surgical access apparatus and method
8703034, Aug 14 2001 Applied Medical Resources Corporation Method of making a tack-free gel
8721537, Oct 13 2008 Applied Medical Resources Corporation Single port access system
8753267, Jan 24 2011 Covidien LP Access assembly insertion device
8758236, May 10 2011 Applied Medical Resources Corporation Wound retractor
8864659, Nov 23 2010 Covidien LP Seal anchor for use in surgical procedures
8870904, Aug 14 2001 Applied Medical Resources Corporation Access sealing apparatus and method
8894571, Oct 13 2008 Applied Medical Resources Corporation Single port access system
8911366, Oct 19 2000 Applied Medical Resources Corporation Surgical access apparatus and method
8932214, Feb 25 2003 Applied Medical Resources Corporation Surgical access system
8961410, May 11 2007 Applied Medical Resources Corporation Surgical retractor with gel pad
8973583, Jun 05 2002 Applied Medical Resources Corporation Wound retractor
9017251, Jan 24 2011 Covidien LP Access assembly insertion device
9017254, Oct 14 2005 Applied Medical Resources Corporation Hand access laparoscopic device
9084594, Jan 10 2012 The Board of Trustees of the Lealand Stanford Junior University; The Board of Trustees of the Leland Stanford Junior University Methods for the prevention of surgical site infections
9101354, Oct 14 2005 Applied Medical Resources Corporation Wound retractor with gel cap
9113951, Oct 05 2007 Covidien LP Seal anchor for use in surgical procedures
9119666, Mar 25 2011 Covidien LP Access port with integrated flexible sleeve
9192366, May 09 2012 Applied Medical Resources Corporation Wound retractor
9241697, May 10 2011 Applied Medical Resources Corporation Wound retractor
9271639, Feb 29 2012 Covidien LP Surgical introducer and access port assembly
9289115, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
9289200, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
9295459, Feb 25 2003 Applied Medical Resources Corporation Surgical access system
9307975, May 10 2011 Applied Medical Resources Corporation Wound retractor
9351761, Mar 25 2011 Covidien LP Access port with integrated flexible sleeve
9393005, Jan 10 2012 The Board of Trustees of the Leland Stanford Junior University Systems for the prevention of surgical site infections
9451980, Dec 20 2010 Covidien LP Hand access device
9474519, Oct 14 2005 Applied Medical Resources Corporation Hand access laparoscopic device
9486197, Dec 20 2010 Covidien LP Two-part access assembly
9532801, Nov 23 2010 Covidien LP Seal anchor for use in surgical procedures
9561024, Jun 05 2002 Applied Medical Resources Corporation Wound retractor
9642608, Jul 18 2014 Applied Medical Resources Corporation Gels having permanent tack free coatings and method of manufacture
9649102, Oct 14 2005 Applied Medical Resources Corporation Wound retractor with split hoops
9669153, Aug 14 2001 Applied Medical Resources Corporation Method of manufacturing a tack-free gel for a surgical device
9707011, Nov 12 2014 Covidien LP Attachments for use with a surgical access device
9788823, Jan 10 2012 The Board of Trustees of the Leland Stanford Junior University Methods for the prevention of surgical site infections
9872702, Oct 01 2010 Applied Medical Resources Corporation Natural orifice surgery system
9878140, Aug 14 2001 Applied Medical Resources Corporation Access sealing apparatus and method
9949730, Nov 25 2014 Applied Medical Resources Corporation Circumferential wound retraction with support and guidance structures
9974564, Mar 14 2013 Prescient Surgical, Inc. Methods and devices for the prevention of incisional surgical site infections
D712033, Oct 02 2008 Covidien LP Seal anchor for use in surgical procedures
D712034, Oct 05 2007 Covidien LP Seal anchor for use in surgical procedures
D736921, Oct 02 2008 Covidien LP Seal anchor for use in surgical procedures
D738500, Oct 02 2008 Covidien LP Seal anchor for use in surgical procedures
ER193,
ER8613,
Patent Priority Assignee Title
1157202,
1810466,
2305289,
2478586,
2812758,
2835253,
2853075,
3039468,
3111943,
3195934,
3244169,
3332417,
3347226,
3347227,
3397692,
3402710,
3416520,
3447533,
3523534,
3717151,
3831583,
3841332,
3850172,
3856021,
3860274,
4024872, Jun 01 1976 Colostomy device and method
4043328, Jun 01 1976 Baxter International Inc Urological drape
4069913, Aug 11 1975 Surgical glove package and fixture
4083370, Nov 03 1976 Bloat relief tube and holder
4188945, Aug 26 1977 Triplus Sjukvardsprodukter AB Surgical cloth
4217664, Feb 02 1979 Prosthesis and method for creating a stoma
4222126, Dec 14 1978 The United States of America as represented by the Secretary of the Unitized three leaflet heart valve
4254973, Apr 30 1979 NIBCO, INC Fluid coupling seal
4338937, Dec 05 1980 Mechanical continent ileostomy or colostomy
4367728, Sep 07 1979 COOPERSURGICAL, INC Isolation apparatus
4369284, Mar 17 1977 ALLIED ELASTOMERICS INCORPORATED Thermoplastic elastomer gelatinous compositions
4454873, Feb 26 1982 Hexcel Corporation Separator medium for orthopedic cast material
4475548, Jun 01 1982 Fitting for endotracheal tube apparatus and method of making the fitting
4550713, Mar 10 1983 Method and apparatus for opposing deformity, displacement, and expulsion of the ocular tissues during open eye surgery
4553537, Jun 09 1983 Kimberly-Clark Worldwide, Inc Surgical barrier
4691942, Aug 13 1986 Hose quick coupling apparatus
4714749, Jul 07 1983 Exxon Research & Engineering Co. Fully saturated petroleum resin and hot melt pressure sensitive adhesive formulations utilizing same as tackifier
4755170, Dec 03 1986 Venipuncture and cutaneous sealing device and method
4777943, Nov 10 1984 MALLINER TECHNOLOGIES, INC 10041 81ST AVENUE, EDMONTON, ABLERTA CANADA T6E 1W7 Use of transparent membranes made of hydrogel polymers as a cover for various organs during surgery
4798594, Sep 21 1987 Cordis Corporation Medical instrument valve
4802694, Oct 26 1987 PARRISH ENTERPRISES, LTD Quick-disconnect coupling
4842931, Jul 19 1988 Affixable padding material using gelatinous viscoelastic polymer
4856502, May 05 1987 Minnesota Mining and Manufacturing Company Curable resin coated sheets having reduced tack
4863438, Nov 29 1985 APPLIED MEDICAL RESEARCH, INC Low profile gastrostomy device
4889107, Feb 10 1988 Surgical retractor
4895565, Sep 21 1987 CORDIS CORPORATION, A FL CORP Medical instrument valve
4903710, Jan 06 1987 Surgical isolation drapes
4911974, Jul 07 1987 Toray Silicone Company, Ltd Tack-free silicone gel moldings
4926882, Sep 06 1988 Transparent shielding device for use with autopsy saw
4950223, Sep 05 1985 Trimark (R&D) Limited Stoma closure devices
4984564, Sep 27 1989 Surgical retractor device
4991593, Jun 13 1989 Minnesota Scientific, Inc. Flexible bag for storing body organs
4998538, Aug 25 1989 Medical drape for laser surgery
5009224, Sep 30 1986 Minnesota Mining and Manufacturing Company Method for attaching a pressure-sensitive film article having high moisture vapor transmission rate
5015228, Jun 05 1989 CLINICAL DIAGNOSTIC SYSTEMS INC Sterilizing dressing device and method for skin puncture
5037379, Jun 22 1990 Vance Products Incorporated Surgical tissue bag and method for percutaneously debulking tissue
5082005, Dec 18 1990 NEW ENGLAND DEACONESS HOSPITAL, A CORP OF MASSACHUSETTS Surgical access device
5159921, Nov 27 1990 Surgical retractor
5178162, Apr 14 1992 Splash and spill resistant extremity irrigation and debridement surgical drape
5192301, Jan 17 1989 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
5207656, Apr 19 1990 Cordis Corporation Medical instrument valve having foam partition member
5213114, Oct 25 1990 Ophthalmologic drape and method
5259366, Nov 03 1992 LOCALMED, INC Method of using a catheter-sleeve assembly for an endoscope
5262468, Mar 17 1977 APPLIED ELASTOMERICS, INC Thermoplastic elastomer gelatinous compositions
5299582, Sep 16 1991 CHASE MANHATTAN BANK, AS AGENT, THE Surgical isolation apparatus
5316541, Jan 19 1993 Enclosure for surgical procedures
5336708, Mar 17 1977 Applied Elastomerics, Inc.; APPLIED ELASTOMERICS, INC Gelatinous elastomer articles
5350364, Oct 18 1991 Ethicon, Inc. Universal seal for trocar assembly
5353786, Jan 24 1992 Surgical lighting method
5366478, Jul 27 1993 Ethicon, Inc. Endoscopic surgical sealing device
5368545, Dec 05 1991 Willy Rusch AG Accessory device for laparoscopic operations
5380288, Mar 30 1993 INNOVASIVE DEVICES, INC Surgical cannula and trocar system and method of using the same
5389080, Jul 26 1990 Endoscopic portal for use in endoscopic procedures and methods therefor
5389081, May 18 1993 United States Surgical Corporation Stabilizer for a valve assembly for introducing instruments into body cavities
5407433, Feb 10 1993 Applied Medical Resources Corporation Gas-tight seal accommodating surgical instruments with a wide range of diameters
5429609, Jul 26 1990 Endoscopic portal for use in endoscopic procedures and methods therefor
5437683, Oct 31 1990 Surgical closure
5441486, Jul 26 1990 Endoscopic portal for use in endoscopic procedures and methods therefor
5456284, May 10 1993 Applied Medical Resources Corporation Elastomeric valve assembly
5460616, Apr 19 1994 Cordis Corporation Catheter introducer with fluid chamber valve
5476475, Nov 23 1992 Applied Medical Resources Trocar with universal seal protector
5480410, Mar 14 1994 IMAGYN MEDICAL TECHNOLOGIES, INC Extracorporeal pneumoperitoneum access bubble
5486426, Oct 04 1993 Jindal Films Americas LLC Cold sealable cohesive polymer coated polyolefin substrate
5492304, Jun 16 1993 United States Surgical Corporation Seal assembly for accommodating introduction of surgical instruments
5496280, Jul 02 1992 Applied Medical Resources Corporation Trocar valve assembly
5503112, Jun 22 1994 LAND O'LAKES, INC. Method for selecting ruminant feed composition using abomasal infusion
5508334, Mar 17 1977 APPLIED ELASTOMERICS, INC Thermoplastic elastomer gelatinous compositions and articles
5514133, Aug 26 1994 Tyco Healthcare Group LP Access device for endoscopic surgery
5518278, Feb 13 1995 Coupling
5522791, Aug 31 1994 Apparatus for retracting an incision and inflating an abdominal cavity
5524644, Jun 09 1995 MCT II, LLC Incrementally adjustable incision liner and retractor
5531758, Mar 25 1994 Ethicon Endo-Surgery, Inc. Sliding reducer seal for surgical trocar
5545179, Jul 21 1995 Ethicon Endo-Surgery, Inc. Endoscopic access assembly
5562677, Jun 30 1992 Ethicon, Inc. Obturator for justing a flexible trocar tube
558364,
5603702, Aug 08 1994 Tyco Healthcare Group LP Valve system for cannula assembly
5628732, Jan 19 1996 Ethicon Endo-Surgery, Inc.; Ethicon Endo-Surgery, Inc Trocar with improved universal seal
5632284, May 22 1996 Barrier eye drape and method of using same
5634911, May 19 1995 General Surgical Innovations, Inc Screw-type skin seal with inflatable membrane
5634936, Feb 06 1995 Boston Scientific Scimed, Inc Device for closing a septal defect
5634937, May 19 1995 General Surgical Innovations, Inc Skin seal with inflatable membrane
5636645, Feb 28 1995 Method and surgical glove for performing laparoscopic-assisted mini laparotomy
5640977, Apr 08 1994 MCT II, LLC Apparatus and method for use in surgery
5649550, Feb 26 1996 MCT II, LLC Surgical retractor liner and integral drape assembly
5653705, Oct 07 1994 General Surgical Innovations, Inc Laparoscopic access port for surgical instruments or the hand
5672168, Oct 07 1994 General Surgical Innovations, Inc Laparoscopic access port for surgical instruments or the hand
5681341, Mar 14 1995 TYCO HEALTHCARE GROUP AG; Covidien AG Flexible lifting apparatus
5709664, Jul 02 1992 Applied Medical Resources Corporation Trocar valve assembly
5720730, Sep 01 1995 Lubricated trocar valve
5728103, Aug 23 1996 Applied Medical Technology, Inc. Implantable subcutaneous access device and method of using same
5741298, Apr 28 1995 Method and devices for video-assisted surgical techniques
5753150, Jun 10 1994 Johnson & Johnson Vision Products, Inc. Low oxygen molding of soft contact lenses
5760117, May 21 1990 APPLIED ELASTOMERICS, INC Gelatinous composition and articles
5782817, Nov 06 1995 Cordis Corporation Catheter introducer having toroidal valve
5788676, Mar 25 1996 Endoscopic portal having multiple universal seals and method of introducing instruments therethrough
5792119, Oct 20 1993 Tubular implant to be used for percutaneously feeding a patient
5795290, Jul 09 1993 BioEnterics Corporation Apparatus for holding intestines out of an operative field
5803919, Jul 02 1992 Applied Medical Resources Corporation Trocar valve assembly
5803921, Feb 18 1994 Gaya Limited Access port device for use in surgery
5803923, Sep 15 1994 Jugvir I., Singh-Derewa Presbyopia correction using a protected space pattern, methods and apparatus
5810721, Mar 04 1996 Edwards Lifesciences, LLC Soft tissue retractor and method for providing surgical access
5813409, Sep 02 1994 MCT II, LLC Surgical apparatus
5814026, Mar 19 1996 Endoscopic portal having a universal seal and methods for introducing instruments therethrough
5819375, Dec 18 1996 Volkswagen AG Tensioning strap
5832925, Jun 09 1997 Minnesota Mining and Manufacturing Company Surgical drape having improved sealing apparatus
5841298, Apr 25 1996 Transpacific IP Ltd Locally asynchronous, pipeline-able logic circuits for true-single-phase synchronous logic circuit
5853395, Feb 18 1997 MEDICAL CREATIVE TECHNOLOGIES, INC Extracorporeal pneumoperitoneum enclosure and method of use
5865729, Oct 10 1997 Olympus America, Inc. Apparatus for facilitating gynecological examinations and procedures
5865807, Sep 01 1995 Seal for trocar
5871474, May 19 1995 General Surgical Innovations, Inc. Screw-type skin seal with inflatable membrane
5895377, Aug 08 1994 Tyco Healthcare Group LP Valve system for cannula assembly
5899208, May 08 1995 Gaya Limited Hand access port
5904703, Nov 07 1997 Medtronic Ave, Inc Occluder device formed from an open cell foam material
5906577, Apr 30 1997 ETHICON ENDO-SURGERY INC Device, surgical access port, and method of retracting an incision into an opening and providing a channel through the incision
5919476, Sep 29 1997 PMT Corporation Reinforced gel sheeting for scar treatment
5947922, Apr 28 1995 Modified surgical glove and methods of use
5951588, Feb 29 1996 RED DRAGON INNOVATIONS, LLC Apparatus and method for protecting a port site opening in the wall of a body cavity
5957888, Oct 10 1995 United States Surgical Corporation Surgical cannula having a variable length
5957913, Oct 07 1994 General Surgical Innovations, Inc Laparoscopic access port for surgical instruments or the hand
5962572, Dec 29 1995 APPLIED ELASTOMERICS, INC Oriented gel and oriented gel articles
5964781, Jun 02 1997 General Surgical Innovations, Inc. Skin seal with inflatable membrane
5989233, Mar 19 1996 Endoscopic portal having a universal seal and methods for introducing instruments therethrough
5989266, Feb 24 1997 Cook Medical Technologies LLC Medical device including basket
5993471, Oct 22 1996 Erol D., Riza; RIZA, EROL D Trocar assembly
5993485, Feb 12 1998 Bladder portal
5997515, May 19 1995 General Surgical Innovations, Inc Screw-type skin seal with inflatable membrane
6010494, Mar 26 1997 Roche Diabetes Care, Inc Connection system for medical applications
6024736, Oct 07 1994 General Surgical Innovations, Inc. Laparascopic access port for surgical instruments or the hand
6025067, Mar 08 1995 Soft elastomeric composite composition
6033426, Jul 29 1997 Olympus Optical Co., Ltd. Access device for surgical treatment
6033428, Jan 26 1999 Laparoscopic surgery device
6035559, Oct 11 1995 GOLDBERG, JACK Shoe with circular pad in the sole to relieve twisting stresses on the ankle
6045535, Jun 13 1996 FORSIGHT VISION6, INC Surgical sealing sleeve
6053934, Jun 02 1997 Cook Medical Technologies LLC Replaceable, medical device handle
6077288, Apr 07 1998 HAKKO CO , LTD Valved trocar jacket tube
6090043, May 17 1999 APPLIED MEDICAL TECHNOLOGY, INC Tissue retractor retention band
6110154, Oct 08 1996 HAKKO CO , LTD Valve and valved trocar jacket tube
6142935, Mar 04 1996 Edwards Lifesciences, LLC Illuminating soft tissue retractor
6142936, Apr 30 1997 ETHICON ENDO-SURGERY INC Surgical access port and method for accessing a patient's body cavity
6149642, Jan 16 1998 MEDICAL CREATIVE TECHNOLOGIES, INC Surgical instrument and method for use in hand-assisted laparoscopy
6150608, May 02 1996 Tyco Electronics Raychem BVBA Seal for sealing an aperture
6162172, Jan 30 1998 Edwards Lifesciences Corporation Methods and apparatus for retracting tissue
6224612, Apr 23 1998 Boston Scientific Scimed, Inc Atraumatic medical retrieval device
6238373, May 19 1995 General Electric Innovations, Inc. Screw-type skin seal with inflatable membrane
6254533, Jul 07 2000 Dexterity Surgical, Inc. Retractor assembly and method for surgical procedures
6254534, Oct 14 1999 Atropos Limited Retractor
6276661, Nov 06 1996 Medtronic Ave, Inc Pressure actuated introducer valve
6287280, Sep 07 1999 Merit Medical Systems, Inc.; Merit Medical Systems, Inc Hemostasis valve apparatus with integral introducer
6319246, Oct 07 1994 General Surgical Innovations, Inc. Laparoscopic access port for surgical instruments or the hand
6325384, Sep 10 1997 Piston Tank Corporation Tank piston with improved seal and wiper
6382211, Jul 21 1997 MCT II, LLC Surgical retractor liner appliance
6383162, Nov 12 1999 Apparatus and method for abdomino-pelvic chemotherapy perfusion and lavage
6413244, Mar 26 1997 Roche Diabetes Care, Inc Catheter system for skin passage units
6440063, Apr 30 1997 ETHICON ENDO-SURGERY INC Surgical access port and laparoscopic surgical method
6450983, Oct 03 2001 MCT II, LLC O-ring for incrementally adjustable incision liner and retractor
6482181, May 28 1997 Tyco Healthcare Group LP Trocar seal system
6485435, Oct 18 2000 The United States of America as represented by the Secretary of the Interior Fistula device and method for in-vivo evaluation of fish egg development
6533734, Jun 11 1999 Board of Trustees of the University of Illinois, The Time-integrated sampler of bodily fluid
6551344, Apr 26 2000 ev3 Endovascular, Inc Septal defect occluder
6578577, Dec 01 1998 JNC Corporation Laparoscopic sealed access device
6579281, Oct 11 2000 MEDICI LIFE SCIENCES LICENSING COMPANY LLC Instrument stabilizer for through-a-port surgery
6582364, Oct 14 1999 Atropos Limited Retractor and method for use
6589167, Oct 08 1997 HAKKO CO , LTD Valve and valved trocar jacket tube
6589211, Apr 28 1995 Modified trocar and methods of use
6613952, Oct 03 2001 MCT II, LLC O-ring for incrementally adjustable incision liner and retractor
6623426, Dec 01 1998 Atropos Limited Laparoscopic sealed access device
6702787, May 02 1997 Covidien LP Trocar seal system
6723044, Mar 14 2002 COOPERSURGICAL, INC Abdominal retractor
6814078, Jul 21 1997 MCT II, LLC Surgical retractor and liner
6846287, Dec 01 1998 Atropos Limited Surgical device for retracting and/or sealing an incision
6866861, Jan 29 1999 LAND O'LAKES, INC. Method and composition for enhancing milk component concentrations
6895965, Sep 08 1995 RIC Investments, LLC Customizable seal, mask with customizable seal and method of using such a seal
6902541, Feb 18 2000 Zevex, Inc. Low-profile enterostomy device
6908430, Jul 30 1999 Applied Medical Resources Corporation Hand access port device
6939296, Oct 17 2001 Applied Medical Resources Corporation Laparoscopic illumination apparatus and method
6945932, Mar 18 1999 Covidien LP Surgical access device
6958037, Oct 20 2001 Applied Medical Resources Corporation Wound retraction apparatus and method
6972026, Mar 18 1999 Covidien LP Surgical access device
6997909, Apr 22 2002 THE CHILDREN S HOSPITAL OF PHILADELPHIA Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
7033319, Mar 14 2002 COOPERSURGICAL, INC Abdominal retractor
7052454, Oct 20 2001 Applied Medical Resources Corporation Sealed surgical access device
7081089, Dec 01 1998 Atropos Limited Surgical device for retracting and/or sealing an incision
7214185, Mar 18 1999 Covidien LP Surgical access device
20010037053,
20010047188,
20020002324,
20020038077,
20020072762,
20030040711,
20030139756,
20030187376,
20030192553,
20030225392,
20040015185,
20040049100,
20040073090,
20040092796,
20040106942,
20040127772,
20040154624,
20040167559,
20040173218,
20040254426,
20040267096,
20050020884,
20050033246,
20050059865,
20050090717,
20050148823,
20050155611,
20050197537,
20050222582,
20050241647,
20050261720,
20050267419,
20050283050,
20050288558,
20060030755,
20060047284,
20060052669,
20060084842,
20060129165,
20060149137,
20060149306,
20060161050,
20070185387,
EP1125552,
IE630650,
IE75368,
IE930649,
IE940150,
IE940613,
IE940960,
IE950055,
IE950266,
IE960196,
IE970810,
IE990218,
IE990219,
IE990220,
IE990660,
IE990795,
JP11290327,
JP200228163,
JP2003235879,
WO32116,
WO32120,
WO35356,
WO54675,
WO54676,
WO54677,
WO108581,
WO126559,
WO234108,
WO3032819,
WO3034908,
WO3061480,
WO3077726,
WO3103548,
WO2004075730,
WO2004075741,
WO2004075930,
WO2005034766,
WO9507056,
WO9522289,
WO9524864,
WO9527468,
WO9711642,
WO9819853,
WO9835614,
WO9848724,
WO9915068,
WO9925268,
///////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 12 2006Applied Medical Resources, Corporation(assignment on the face of the patent)
Oct 20 2006HART, CHARLES C Applied Medical Resources CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0184960397 pdf
Oct 25 2006JOHNSON, GARY M Applied Medical Resources CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0184960397 pdf
Oct 31 2006BRUSTAD, JOHN R Applied Medical Resources CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0184960397 pdf
Nov 01 2006ALBRECHT, JEREMY J Applied Medical Resources CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0184960397 pdf
Apr 17 2012Applied Medical Resources CorporationCITIBANK, N A SECURITY AGREEMENT0281150276 pdf
May 31 2017Applied Medical Resources CorporationJPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0426690725 pdf
Jun 25 2021JPMORGAN CHASE BANK, N A Applied Medical Resources CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0567510169 pdf
Jun 25 2021Applied Medical Resources CorporationCITIBANK, N A SECURITY INTEREST SEE DOCUMENT FOR DETAILS 0566830001 pdf
Jan 29 2024CITIBANK N A , AS ADMINISTRATIVE AGENTApplied Medical Resources CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0667950595 pdf
Feb 27 2024Applied Medical Resources CorporationBMO BANK N A , AS ADMINISTRATIVE AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0667020123 pdf
Date Maintenance Fee Events
Apr 21 2014M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Apr 19 2018M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Apr 19 2022M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Oct 19 20134 years fee payment window open
Apr 19 20146 months grace period start (w surcharge)
Oct 19 2014patent expiry (for year 4)
Oct 19 20162 years to revive unintentionally abandoned end. (for year 4)
Oct 19 20178 years fee payment window open
Apr 19 20186 months grace period start (w surcharge)
Oct 19 2018patent expiry (for year 8)
Oct 19 20202 years to revive unintentionally abandoned end. (for year 8)
Oct 19 202112 years fee payment window open
Apr 19 20226 months grace period start (w surcharge)
Oct 19 2022patent expiry (for year 12)
Oct 19 20242 years to revive unintentionally abandoned end. (for year 12)